Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2023-04-07

Clinical Trial Update: In Hospital IM Naltrexone: A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating in-hospital intramuscular naltrexone for alcohol use disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • In Hospital IM Naltrexone (naltrexone)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Alcohol Use Disorder | Phase 4 | Status: WITHDRAWN